Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese mice

Rivera-Gonzalez O., Mills MF., Konadu BD., Wilson NA., Murphy HA., Newberry MK.

Animal Study on Type 2 Diabetes, published in Acta Physiol (Oxf) (2024) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Acta Physiol (Oxf) (2024)
Reported sample size
—
Source database
Europe PMC
PMID
39096077
PMCID
PMC11421981
DOI
10.1111/apha.14214
Citations
8

Abstract (original English)

Aims Endothelin-1 (ET-1) is elevated in patients with obesity and adipose tissue of obese mice fed high-fat diet (HFD); however, its contribution to the pathophysiology of obesity is not fully understood. Genetic loss of endothelin type B receptors (ET B ) improves insulin sensitivity in rats and leads to increased circulating adiponectin, suggesting that ET B activation on adipocytes may contribute to obesity pathophysiology. We hypothesized that elevated ET-1 in obesity promotes insulin resistance by reducing the secretion of insulin sensitizing adipokines, via ET B receptor. Methods Male adipocyte-specific ET B receptor knockout (adET B KO), overexpression (adET B OX), or control littermates were fed either normal diet (NMD) or high-fat diet (HFD) for 8 weeks. Results RNA-sequencing of epididymal adipose (eWAT) indicated differential expression of over 5500 genes (p B KO mice. KEGG analysis indicated significant increase in metabolic signaling pathway. HFD adET B KO mice had significantly improved glucose and insulin tolerance compared to HFD control. In addition, adET B KO attenuated changes in plasma adiponectin, insulin, and leptin that is observed in HFD versus NMD control mice. Treatment of primary adipocytes with ET-1 caused a reduction in adiponectin production that was attenuated in cells pretreated with an ET B antagonist. Conclusion These data indicate elevated ET-

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cells, CulturedAdipocytesAnimalsMice, Inbred C57BLInsulin ResistanceObesityInsulinBlood GlucoseReceptor, Endothelin BAnimal Feed

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research